The Patient Confusion Crisis
Pharma faces a $5B crisis as 35-40% of patients abandon specialty prescriptions. Misinformation from social media is eroding treatment adherence.
- Publisher
- Hoot Health, Inc.
- Length
- 13 pages
- File
- 220 KB PDF
Download the full 13-page PDF
Free · 220 KB · Instant access after email
This white paper presents a data-driven analysis of the patient confusion crisis affecting treatment initiation and adherence in complex therapies.
- 35-40% of patients abandon specialty prescriptions before the first fill.
- 50% of patients who start therapy discontinue within 12 months.
- Only 3% of patients utilize existing $5 billion patient support programs.
- 92% of patients trust their prescribing physician over other information sources.
- Proposes physician-led video education via SMS to improve patient engagement and adherence.
Ready to read the full report?
Join 12,000+ pharma leaders getting deep industry analysis delivered weekly.
More whitepapers like this
Strategies to Enhance Recruitment of Female Participants to Cardiovascular Research
This consensus document outlines strategies to increase female representation in cardiovascular clinical trials, addressing significant under-representation of women.
British Society of Gastroenterology Guidelines on Inflammatory Bowel Disease in Adults: 2025
The updated BSG guidelines emphasize the necessity of ileocolonoscopy for IBD diagnosis and advocate for immunomodulators in all patients.
🔒 Agentic AI for Pharma Launches: Access & Engagement
Agentic AI can enhance pharma launches by improving market access and HCP engagement, with potential efficiency gains of up to 80%.